Showing results (51-60 of 165) with videos related to
Sort By:
Pageof 17
Journal of the National Comprehensive Cancer Network : JNCCN|November 17, 2018
The Adrenal Gland as a Sanctuary Site of Metastases After Pembrolizumab Treatment: A Case SeriesMichelle C Nguyen, Manisha H Shah, David A Liebner, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 20, 2015
Endometrial Cancer Insulin-Like Growth Factor 1 Receptor (IGF1R) Expression Increases with Body Mass Index and Is Associated with Pathologic Extent and PrognosisAmy S Joehlin-Price, Julie A Stephens, Jianying Zhang, et al.American Journal of Obstetrics and Gynecology|August 5, 2022
Less is more: clinical utility of postoperative laboratory testing following minimally invasive hysterectomy for endometrial cancerMichelle D S Lightfoot, Ashley S Felix, Corinne A Calo, et al.Gynecologic Oncology|August 13, 2017
Genetic consultation embedded in a gynecologic oncology clinic improves compliance with guideline-based careLeigha Senter, David M O'Malley, Floor J Backes, et al.Gynecologic Oncology|September 10, 2002
Chylous ascites following treatment for gynecologic malignanciesTom P Manolitsas, Shahab Abdessalam, Jeffrey M FowlerJournal of Surgical Oncology|September 20, 2015
The role of robotic surgery in endometrial cancerDavid M O'Malley, Blair Smith, Jeffrey M FowlerFrontiers in Oncology|April 24, 2023
Epigenetic MMR defect identifies a risk group not accounted for through traditional risk stratification algorithms in endometrial cancerCourtney J Riedinger, Morgan Brown, Paulina J Haight, et al.Gynecologic Oncology|July 16, 2017
Epigenetic silencing of MLH1 in endometrial cancers is associated with larger tumor volume, increased rate of lymph node positivity and reduced recurrence-free survivalCasey M Cosgrove, David E Cohn, Heather Hampel, et al.Gynecologic Oncology Case Reports|November 27, 2014
Bilateral groin reconstruction with a single anterolateral thigh perforator flap as an alternative to traditional myocutaneous flapsAlbert H Chao, Georgia A McCann, Jeffrey M FowlerFuture Oncology (London, England)|January 17, 2025
Real-world outcomes of first-line maintenance niraparib monotherapy in patients with epithelial ovarian cancerRitu Salani, Tirza Areli Calderón Boyle, Jonathan Lim, et al.Pageof 17